You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
@@ -68,7 +68,7 @@ The following is a list of every version of `tbp-parser` and a short summary of
- v2.2.0 - removes ciprofloxacin, fluoroquinolones, and ofloxacin from gyrA and gyrB and aminoglycosides from rrs in the `globals.GENE_TO_ANTIMICROBIAL_DRUG_NAME` dictionary; if a drug is missing in the TBProfiler JSON's gene_associated_drug field that is present in that global dictionary, it will be added for the mutation.
- v2.2.1 - fixes a bug where rifampicin was not renamed to rifampin, which caused duplicate lines to appear in the Laboratorian report.
- v2.2.2 - removes the high-level and low-level resistance comments from the LIMS report
- v2.3.0 - reworks the lineage detection so that if TBProfiler detects a lineage, it is reported; if no lineage is reported by TBProfiler, then whether or not M.tb was detected depends on the percentage of LIMS genes above a (now lower) default percentage of 0.7
- v2.3.0 - reworks the lineage detection so that if TBProfiler detects a lineage, it is reported; if no lineage is reported by TBProfiler, then whether or not M.tb was detected depends on the percentage of LIMS genes above a (now lower) default percentage of 0.7; all pytests have been fixed as well
